Teva Launches Generic Version Of Ivermectin Cream, 1% In The U.S. - Quick Facts

(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Israeli generic drug maker Teva Pharmaceutical Industries Ltd. (TEVA), announced Wednesday the U.S. launch of its generic version of once daily Soolantra (ivermectin) Cream, 1% for the treatment of inflammatory lesions of rosacea.

With nearly 550 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market. Currently, 1 in 11 generic prescriptions dispensed in the U.S. is filled with a Teva generic product.

Soolantra had annual sales of more than $115 million in the U.S., according to IQVIA data as of April 2021.